Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Xtremepicks Alerts Message Board

$PPHM News Apollo slammed on education departm

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 89377
Posted On: 01/19/2015 12:52:22 PM
Avatar
Posted By: Stock_Tracker
$PPHM News

Apollo slammed on education department review 5:09 p.m. July 14, 2014 - Tom Bemis
Peregrine plunges on test data 3:17 p.m. June 27, 2013 - Russ Britt
Small-cap makes a splash with FDA nod for cancer drug 2:16 p.m. May 20, 2013 - Russ Britt
Peregrine drug shows promise in pancreatic cancer 12:17 p.m. Feb. 13, 2013 - MarketWatch.com
In focus: Bullish, but overbought 7:06 p.m. Jan. 9, 2013 - Lawrence G. McMillan
Hedge funds are bullish on these stocks 10:57 a.m. Dec. 5, 2012 - Insider Monkey
Peregrine, FDA agree on brain-cancer drug study 10:56 a.m. Dec. 5, 2012 - MarketWatch.com
Drug trial contractors improve efficiency 9:24 a.m. Nov. 16, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:42 p.m. Sept. 25, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 4:09 p.m. Sept. 25, 2012 - Greg Morcroft
Peregrine Pharma down 86% after test data review 7:27 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine Pharma down 86% in premarket 7:18 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine reviewing Bavituximab results 6:42 a.m. Sept. 24, 2012 - Greg Morcroft
Some previous Bavituximab data not valideregrine 6:42 a.m. Sept. 24, 2012 - Greg Morcroft
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Regions Financial, Williams-Sonoma hit 52-week highs; Intel, Cisco active 10:11 a.m. Sept. 10, 2012 - blogs.marketwatch.com
Stocks to watch Monday: AIG, Michael Kors, Sears 5:41 a.m. Sept. 10, 2012 - MarketWatch
Peregrine rallies on bavituximab lung-cancer data 12:29 p.m. Sept. 7, 2012 - MarketWatch.com
Monday’s biggest gaining & declining stocks 1:53 p.m. Aug. 27, 2012 - MarketWatch
Peregrine Pharma slides 12% after negative report 1:21 p.m. Aug. 27, 2012 - Val Brickates Kennedy


12 Biotech Stocks to Watch in 2015 8:45 a.m. Jan. 9, 2015 - InvestorPlace.com
Peregrine Pharmaceuticals Series E Preferred Stock Shares Cross 12% Yield Mark 2:14 p.m. Dec. 18, 2014 - TheStreet.com
Ex-Div Reminder For Peregrine Pharmaceuticals Series E Convertible Preferred Stock 2:11 p.m. Dec. 15, 2014 - TheStreet.com
Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q2 2015 Results - Earnings Call Transcript 4:39 a.m. Dec. 11, 2014 - Seeking Alpha
Peregrine Pharmaceuticals (PPHM) Q2 2015 Results - Earnings Call Webcast 4:25 p.m. Dec. 10, 2014 - Seeking Alpha
10-Q: PEREGRINE PHARMACEUTICALS INC 4:23 p.m. Dec. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining 7:59 a.m. Nov. 13, 2014 - Seeking Alpha
Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape 8:39 a.m. Oct. 16, 2014 - Zacks.com
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog 8:00 a.m. Sept. 10, 2014 - Zacks.com
Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q1 2015 Results - Earnings Call Transcript 6:53 p.m. Sept. 9, 2014 - Seeking Alpha
10-Q: PEREGRINE PHARMACEUTICALS INC 3:29 p.m. Sept. 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Peregrine Pharmaceuticals (PPHM) Q1 2015 Results - Earnings Call Webcast 3:25 p.m. Sept. 9, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 2:12 p.m. Aug. 27, 2014 - Seeking Alpha
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 9:43 a.m. Aug. 12, 2014 - Seeking Alpha
Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog 10:00 a.m. July 15, 2014 - Zacks.com
Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q4 2014 Results - Earnings Call Transcript 9:21 p.m. July 14, 2014 - Seeking Alpha
10-K: PEREGRINE PHARMACEUTICALS INC 4:00 p.m. July 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
More on Peregrine fiscal Q4 and fiscal year results 3:26 p.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 8:30 a.m. July 14, 2014 - TheStreet.com
First Week Of January 2015 Options Trading For Peregrine Pharmaceuticals (PPHM) 10:09 a.m. May 20, 2014 - TheStreet.com


Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in Combination With Sorafenib Presented at ASCO Gastrointestinal Cancers Symposium 9:31 a.m. Jan. 16, 2015 - Marketwired
Data to Be Presented at 2014 San Antonio Breast Cancer Symposium Demonstrate Immune-Stimulatory Properties of Peregrine Pharmaceuticals' Bavituximab in Models of Breast Cancer 8:01 a.m. Dec. 12, 2014 - Marketwired
Peregrine Pharmaceuticals Reports Second Quarter Fiscal Year 2015 Financial Results and Recent Developments 4:03 p.m. Dec. 10, 2014 - Marketwired
Avid Bioservices Announces Expansion of cGMP Manufacturing Capacity 8:06 a.m. Dec. 10, 2014 - Marketwired
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock 4:00 p.m. Dec. 9, 2014 - Marketwired
Peregrine Pharmaceuticals to Report Second Quarter Fiscal 2015 Financial Results After Market on December 10, 2014 4:01 p.m. Dec. 3, 2014 - Marketwired
Phase II Clinical Data Presented at SITC Annual Meeting Support Immunotherapeutic Mechanism of Action of Peregrine Pharmaceuticals' Bavituximab in Liver Cancer 7:32 a.m. Nov. 10, 2014 - Marketwired
Data to Be Presented at the SITC Annual Meeting Support Synergy of PS-Targeting and Anti-CTLA-4 Immunotherapies to Enhance Anti-Tumor Treatments in Melanoma 7:45 a.m. Nov. 7, 2014 - Marketwired
Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer 8:43 a.m. Oct. 30, 2014 - Marketwired
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Data to Be Published in the Journal of Immunology Research Support Phosphatidylserine (PS) as a Potential Target in Ebola Infection 7:05 a.m. Oct. 15, 2014 - Marketwired
Data to Be Presented at CRI Immunotherapy Conference Show PS-Targeting Antibodies Enhance the Anti-Tumor Activity of Immune Checkpoint Inhibitors by Decreasing Levels of Myeloid Derived Suppressor Cells (MDSC) in the Tumor Microenvironment 7:03 a.m. Oct. 6, 2014 - Marketwire
Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2015 Financial Results and Recent Developments 3:01 p.m. Sept. 9, 2014 - Marketwire
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock 3:00 p.m. Sept. 8, 2014 - Marketwire
Peregrine Pharmaceuticals to Report First Quarter Fiscal Year 2015 Financial Results After Market Close on September 9, 2014 3:01 p.m. Sept. 2, 2014 - Marketwire
Preclinical Data Presented at Annual Immunotherapies and Vaccine Summit Show That the Combination of Peregrine Pharmaceuticals' PS-Targeting Antibodies and Anti-PD-1 Antibodies Significantly Reduce Breast Cancer Progression 7:03 a.m. Aug. 11, 2014 - Marketwire
Small companies lead the I-O class of Cancer Therapies 7:03 a.m. Aug. 8, 2014 - ACCESSWIRE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Reports Fourth Quarter and Year-End Fiscal Year 2014 Financial Results and Recent Developments 3:01 p.m. July 14, 2014 - Marketwire
Peregrine Pharmaceuticals to Report Fourth Quarter and Year-End Fiscal 2014 Financial Results After Market on July 14, 2014 3:00 p.m. July 7, 2014 - Marketwire



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us